| Study to Evaluate the Safety, Tolerability and PK of EC-18 After Oral Administration in Healthy Volunteers (NCT02532712) | Enzychem Lifesciences Corporation | 2015-03-01 |
| Once Daily Aminoglycoside Pharmacokinetics and Optimal Dosing in the Burn Population: A Prospective Study (NCT02269969) | Sandra Walker | 2015-03-01 |
| Evaluating the Clinical and Immune Response to Two Dengue Virus Vaccines in Healthy Adults (NCT02392325) | National Institute of Allergy and Infectious Diseases (NIAID) | 2015-03-01 |
| A Single Dose Study of KHK6640 in Japanese Patients With Alzheimer's Disease. (NCT02377713) | Kyowa Kirin Co., Ltd. | 2015-03-01 |
| Ketamine Trial for the Treatment of Depression (NCT02401139) | The University of New South Wales | 2015-03-01 |
| Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes (NCT01313533) | St. Luke's Hospital, Chesterfield, Missouri | 2015-03-01 |
| Assessment of a Syringe Pump to Pre-eclamptic Women in a Low-resource Hospital (NCT02296931) | William Marsh Rice University | 2015-03-01 |
| Study to Evaluate the Safety and Tolerability of a New Drug Named Lu AF20513 in Patients With Mild Alzheimer's Disease (NCT02388152) | H. Lundbeck A/S | 2015-03-01 |
| Dose-escalation, Repeated and Single Oral Dosing Study (NCT02419820) | IlDong Pharmaceutical Co Ltd | 2015-03-01 |
| BAY1238097, First in Man (NCT02369029) | Bayer | 2015-03-01 |
| A Study to Assess the Safety of MEDI7836 in Healthy Adults. (NCT02388347) | MedImmune LLC | 2015-03-01 |
| An Assessment of Buprenorphine Transdermal Delivery System (BTDS) Patch Adhesion (NCT02431624) | Mundipharma Research Limited | 2015-03-01 |
| To Evaluate the Safety, Tolerability, PK, PK-PD Relation of KD101 in the Fed State in Obese or Overweight Subjects (NCT02462031) | Kwang Dong Pharmaceutical co., ltd. | 2015-03-01 |
| Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO) (NCT02368119) | University of Maryland, Baltimore | 2015-03-01 |
| Pilot Clinical Trial of Ustekinumab in Patients With New-onset T1D (NCT02117765) | University of British Columbia | 2015-03-01 |
| Safety, Tolerability,Pharmacokinetics and Pharmacodynamics of ODM-106 in Healthy Volunteers (NCT02393950) | Orion Corporation, Orion Pharma | 2015-03-01 |
| A Bioequivalence Study of TAK-536 Pediatric Formulation (NCT02401464) | Takeda | 2015-03-01 |
| A Study of Certolizumab Pegol to Evaluate Pharmacokinetics and Safety in Adult Healthy Chinese Subjects (NCT02365948) | UCB Pharma SA | 2015-03-01 |
| Trial of SBRT With Concurrent Ipilimumab in Metastatic Melanoma (NCT02406183) | Radiotherapie | 2015-03-01 |
| Safety and Efficacy Study of Gene Therapy Drug (Neovasculgen) to Treat Secondary Raynaud's Phenomenon (NCT02356809) | Artgen Biotech | 2015-03-01 |
| Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne (NCT02593383) | Lee's Pharmaceutical Limited | 2015-03-01 |
| Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Young Volunteers (Single-ascending Dose) (NCT02534480) | NeuroGenetic Pharmaceuticals Inc | 2015-03-01 |
| Probiotics in the Reduction of Antibiotic Associated Diarrhea (NCT02589964) | TriHealth Inc. | 2015-03-01 |
| Phase Ib and Phase II Studies of MK-3475 in Combination + for Renal Cell Carcinoma: (NCT02348008) | Arkadiusz Z. Dudek, MD | 2015-03-01 |
| Dose Escalation Study of AST-OPC1 in Spinal Cord Injury (NCT02302157) | Lineage Cell Therapeutics, Inc. | 2015-03-01 |
| A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan (NCT02343250) | IlDong Pharmaceutical Co Ltd | 2015-03-01 |
| Relative Bioavailability Study of Phase III Tablet Formulation of Cabotegravir (NCT02345707) | ViiV Healthcare | 2015-03-01 |
| A Study of LY2409021 Formulations in Healthy Participants (NCT02385084) | Eli Lilly and Company | 2015-03-01 |
| A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of PF-06649751 in Subjects With Idiopathic Parkinson's Disease (NCT02373072) | Pfizer | 2015-03-01 |
| High-dose Cyclophosphamide for Severe Refractory Crohn Disease (NCT01836289) | Johns Hopkins University | 2015-03-01 |
| First-in-human Study to Evaluate Safety, Tolerability and Pharmacokinetics of Various Doses of BCD-085 in Healthy Subjects (NCT02380287) | Biocad | 2015-03-01 |
| Effect of BI 1181181 on Midazolam, Warfarin, Omeprazole and Digoxin (NCT02345304) | Boehringer Ingelheim | 2015-03-01 |
| Study to Determine Safety, Pharmacokinetics and Efficacy of GMI-1271 in Combination With Chemotherapy in AML (NCT02306291) | GlycoMimetics Incorporated | 2015-03-01 |
| TAP Block With Liposomal Bupivacaine Versus Pre-incisional Wound Infiltration With Bupivacaine for Postoperative Pain (NCT02400645) | University of Tennessee | 2015-03-01 |
| A Study of BBI503 in Advanced Solid Tumors, or BBI503/ Sorafenib in Advanced Hepatocellular Carcinoma (NCT02354898) | Sumitomo Pharma Co., Ltd. | 2015-03-01 |
| A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GLWL-01 (NCT02377362) | GLWL Research Inc. | 2015-03-01 |
| Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage (NCT01878136) | Rush University Medical Center | 2015-03-01 |
| Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage (NCT02367248) | Capital Medical University | 2015-03-01 |
| A Study of Sinotecean on Tolerance and Pharmacokinetics (NCT02469883) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2015-03-01 |
| Evaluation of the Safety and Tolerability of i.v. Administration of a Cancer Vaccine in Patients With Advanced Melanoma (NCT02410733) | BioNTech SE | 2015-03-01 |
| Study of ST266 Eye Drops in Treating Dry Eye (NCT02369861) | Noveome Biotherapeutics, formerly Stemnion | 2015-03-01 |
| Safety and Immunogenicity of Direct Venous Inoculation of a Radiation-attenuated PfSPZ Vaccine in Equatoguinean Adults (NCT02418962) | Sanaria Inc. | 2015-03-01 |
| A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma (NCT02315534) | Sumitomo Pharma America, Inc. | 2015-03-01 |
| A Phase I Trial of 4SCAR19 Cells in the Treatment of Relapsed and Refractory B Cell Leukemia (NCT02968472) | The First People's Hospital of Yunnan | 2015-03-01 |
| Sofosbuvir/Pegylated-interferon Plus Ribavirin With HCV Genotype 4 (NCT04382339) | Beni-Suef University | 2015-03-01 |
| An Open Label Study Evaluating the Effectiveness of Omega Q Plus® Resveratrol at Increasing Blood Levels of CoQ10 (NCT02415114) | KGK Science Inc. | 2015-03-01 |
| A Study to Evaluate the Safety and Immunogenicity of Heterologous Prime-Boost Ebola Vaccine Regimens in Healthy Participants (NCT02376426) | Crucell Holland BV | 2015-03-01 |
| Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts (NCT02402595) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2015-03-01 |
| Improvement of Colonoscopy Preparation by New Media (APP) (NCT02512328) | Technical University of Munich | 2015-03-01 |
| A Study Evaluating CPI-1205 in Patients With B-Cell Lymphomas (NCT02395601) | Constellation Pharmaceuticals | 2015-03-01 |
| Flaxseed as Maintenance Therapy for Ovarian Cancer Patients in Remission (NCT02324439) | Southern Illinois University | 2015-03-01 |
| Dose-escalation Phase 1 to Evaluate the Safety and Efficacy of MG1111 in Healthy Adults (NCT02367638) | Green Cross Corporation | 2015-03-01 |
| A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China. (NCT02401373) | First Affiliated Hospital of Zhejiang University | 2015-03-01 |
| Assessment of Intranasal Glucagon on Endogenous Glucose Production (NCT02740829) | University Health Network, Toronto | 2015-03-01 |
| Beta Cell Function and Related Pharmacodynamics of HMS5552 in T2DM Patients (NCT02386982) | Hua Medicine Limited | 2015-03-01 |
| A Phase I Bioavailability and Pharmacokinetic Study of [14C]-Ipatasertib Single Oral and Intravenous Doses in Healthy Male Subjects (NCT02390492) | Genentech, Inc. | 2015-03-01 |
| Pharmacokinetics and Safety of ABT-493 and ABT-530 in Subjects With Normal and Impaired Renal Function (NCT02442258) | AbbVie | 2015-03-01 |
| Use of Intravenous Tranexamic Acid During Myomectomy (NCT02620748) | George Washington University | 2015-03-01 |
| Bioequivalence Study - Reference Clinical Fexinidazole Tablet Versus Proposed Market Formulation (NCT02571062) | Drugs for Neglected Diseases | 2015-03-01 |
| Ketamine Treatment for Pediatric-Refractory Obsessive-Compulsive Disorder (OCD) (NCT02422290) | New York State Psychiatric Institute | 2015-03-01 |
| Pharmacokinetic Properties of Vortioxetine in Healthy Young Chinese Men and Women (NCT02386488) | H. Lundbeck A/S | 2015-03-01 |
| A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of FB825 in Healthy Volunteers (NCT02309762) | Fountain Biopharma Inc. | 2015-03-01 |
| Hespecta Vaccination in HPV+ Tumors or Malignant Lesions (NCT02821494) | Leiden University | 2015-03-01 |
| DC Vaccination for Post-remission Therapy in AML (NCT02405338) | Medigene AG | 2015-03-01 |
| Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects (NCT02379793) | LEO Pharma | 2015-03-01 |
| Effect of Visceral and Parietal Peritoneum Suturation on Postoperative Vital Signs (NCT02581293) | Zeynep Kamil Maternity and Pediatric Research and Training Hospital | 2015-03-01 |
| Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL (NCT02367547) | Joint Authority for Päijät-Häme Social and Health Care | 2015-03-01 |
| Safety Study of Filler Agent Composed of Autologous Mesenchymal Stem Cells and Hyaluronic Acid (NCT02034786) | Cryopraxis Criobiologia Ltda. | 2015-03-01 |
| Phase I Dose Escalation Study of Topotecan and Pazopanib in Children With Recurrent/Refractory Solid Tumours (NCT02303028) | The Hospital for Sick Children | 2015-03-01 |
| Multiple Ascending Dose Study in Healthy Volunteers (NCT02404922) | Concert Pharmaceuticals | 2015-03-01 |
| FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas (NCT02371031) | Washington University School of Medicine | 2015-03-01 |
| Allogeneic Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients (NCT02387151) | Leiden University Medical Center | 2015-03-01 |
| Bimatoprost Ocular Insert Pharmacokinetic Study (NCT02444767) | ForSight Vision5, Inc. | 2015-03-01 |
| Study of Efficacy and Safety of LJM716 and Cetuximab in Head and Neck Squamous Cell Carcinoma Patients (NCT02143622) | Novartis Pharmaceuticals | 2015-03-01 |
| Dovitinib in Combination With Imatinib in Patients With Gastrointestinal Stromal Tumors (NCT02268435) | Asan Medical Center | 2015-03-01 |
| Retained Urine Volume and Bacteriuria in Traditional Versus Vented Urine Drainage Systems (NCT02052674) | University of Florida | 2015-03-01 |
| A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy (NCT02419001) | Theriva Biologics, Inc. | 2015-03-01 |
| Laboratory Studies on Oxytocin for Treatment of Alcohol Use Disorder (NCT02407340) | Johns Hopkins University | 2015-03-01 |
| Karolinska Interventional Study of Mammograhic Density (Karisma-1) (NCT04079517) | Karolinska Institutet | 2015-03-01 |
| Efficacy of Quetiapine for Pediatric Delirium (NCT02056171) | Weill Medical College of Cornell University | 2015-03-01 |
| Improving Functioning in Persons With Chronic Pain Post-SCI Through Virtual Classroom Education (NCT02561676) | Kessler Foundation | 2015-03-01 |
| Single and Multiple Rising Dose Study of Safety and PK of Metyrapone/Oxazepam Combination (EMB-001) (NCT02406066) | Embera NeuroTherapeutics, Inc. | 2015-03-01 |
| Study to Evaluate Safety, Tolerability and PK of C-10355 and C-10358 in Healthy Subjects (NCT02392702) | Concert Pharmaceuticals | 2015-03-01 |
| Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic Impairment (NCT02367872) | Takeda | 2015-03-01 |
| The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man (NCT02518932) | Elahi, Dariush, PhD | 2015-03-01 |
| A Food-Drug Interaction Study of Serum Urate After Oral Inosine (NCT02614469) | Michael Alan Schwarzschild | 2015-03-01 |
| Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion (NCT02243813) | Johns Hopkins University | 2015-03-01 |
| Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell Transplantation (NCT01483274) | University of Louisville | 2015-03-01 |
| Phase 1 Study of CM082 in Patients With wAMD (NCT02452385) | AnewPharma | 2015-03-01 |
| Bioavailability of Blackberry Juice Anthocyanins (NCT02613715) | Universidade do Porto | 2015-03-01 |
| Oxytocin Trial in Prader-Willi Syndrome (NCT02013258) | University of Florida | 2015-03-01 |
| A Single Session Intervention For Fear Of Recurrence In Breast Cancer Patients (NCT02357927) | University of St Andrews | 2015-03-01 |
| Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis (NCT02377895) | 3E Therapeutics Corporation | 2015-03-01 |
| Racial Differences in Vagal Control of Glucose Homeostasis (NCT02365285) | Vanderbilt University Medical Center | 2015-03-01 |
| A Dose Escalation Safety Study of Locally-Delivered Gemcitabine in Pancreatic Cancer (NCT02237157) | RenovoRx | 2015-03-01 |
| A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer (NCT02396368) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2015-03-01 |
| Treatment of Actinic Keratoses (AK) on the Face (NCT02411851) | Icahn School of Medicine at Mount Sinai | 2015-03-01 |
| Study in Healthy Volunteers and COPD Patients to Evaluate the Efficacy and Safety of Inhaled TV46017 (NCT02315131) | Teva Branded Pharmaceutical Products R&D, Inc. | 2015-03-01 |
| Study to Determine the Maximum Tolerated Dose, Safety and Tolerability of a Single Dose of Lanreotide Prolonged Release Formulation (PRF) in Subjects With Acromegaly (NCT02396953) | Ipsen | 2015-03-01 |
| Istaroxime Infusion for 24 Hours in Chinese Healthy Volunteers (NCT02477449) | Lee's Pharmaceutical Limited | 2015-03-01 |